Antifungal drug response in an in vitro model of dermatophyte nail infection

References

• Heikkila H, Stubb S. The prevalence of onychomycosis in Finland. Br J Dermatol 1995; 133: 699–703.
   PubMed Web of Science ®Google Scholar
• Sigurgeirsson B, Steingrimsson 0, Sveinsdottir S. Prevalence of onychomycosis in Iceland: a population-based study. Acta Derm Venereol 2002; 82: 467–469.
   PubMed Web of Science ®Google Scholar
• Ghannoum MA, Hajjeh RA, Scher R, Konnikov N, Gupta AK, Summerbell R, et al. A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns. J Am Acad Dermatol 2000; 43: 641–648.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Konnikov N, Lynde CW, Summerbell RC, Albreski D, Baran R, et al. Onychomycosis: predisposed populations and some predictors of suboptimal response to oral antifungal agents. Eur J Dermatol 1999; 9: 633–638.
   PubMed Web of Science ®Google Scholar
• Evans EG. Causative pathogens in onychomycosis and the possibility of treatment resistance: a review. J Am Acad Dermatol 1998; 38(5 Pt 3): S32—S36.
   Google Scholar
• Weitzman I, Summerbell RC. The dermatophytes. Gun Microbiol Rev 1995; 8: 240–259.
   PubMed Web of Science ®Google Scholar
• Ryder NS. Terbinafine: mode of action and properties of the squalene epoxidase inhibition. Br J Dermatol 1992; 126(S39): 2–7.
   PubMed Web of Science ®Google Scholar
• Jessup CJ, Ryder NS, Ghannoum MA. An evaluation of the in vitro activity of terbinafine. Med Mycol 2000; 38: 155–159.
   PubMed Web of Science ®Google Scholar
• Fernandez-Torres B, Vazquez-Veiga H, Llovo X, Pereiro M Jr, Guano J. In vitro susceptibility to itraconazole, clotrimazole, ketoconazole and terbinafine of 100 isolates of Trichophyton rubrum. Chemotherapy 2000; 46: 390–394.
   PubMed Web of Science ®Google Scholar
• Fernandez-Torres B, Carrillo AJ, Martin E, Del Palacio A, Moore MK, Valverde A, et al. In vitro activities of 10 antifungal drugs against 508 dermatophyte strains. Ant imicrob Ag Chemother 2001; 45: 2524–2528.
   Google Scholar
• Perea S, Fothergill AW, Sutton DA, Rinaldi MG. Comparison of in vitro activities of voriconazole and five established antifungal agents against different species of dermatophytes using a broth macrodilution method. J Clin Microbiol 2001; 39: 385–388.
   PubMed Web of Science ®Google Scholar
• Arzeni D, Barchiesi F, Compagnucci P, Cellini A, Simonetti 0, Offidani AM, et al. In vitro activity of terbinafine against clinical isolates of dermatophytes. Medical Mycology 1998; 36: 235–237.
   Google Scholar
• Hofbauer B, Leitner I, Ryder NS. In vitro susceptibility of Microsporum canis and other dermatophyte isolates from veter-inary infections during therapy with terbinafine or griseofulvin. Med Mycol 2002; 40: 179–183.
   Google Scholar
• Petranyi G, Meingassner JG, Mieth H. Antifungal activity of the allylamine derivative terbinafine in vitro. Antimicrob Ag Che-mother 1987; 31: 1365–1368.
   Google Scholar
• Nimura K, Niwano Y, Ishiduka S, Fukumoto R. Comparison of in vitro antifungal activities of topical antimycotics launched in 1990s in Japan. Int J Antimicrobl Agents 2001; 18: 173–178.
   PubMed Web of Science ®Google Scholar
• Hazen KC. Fungicidal versus fungistatic activity of terbinafine and itraconazole: an in vitro comparison. J Am Acad Dermatol 1998; 38(5 Pt 3): S37—S41.
   Google Scholar
• Gupta AK, Ahmad I, Summerbell RC. Comparative efficacies of commonly used disinfectants and antifungal pharmaceutical spray preparations against dermatophytic fungi. Med Mycol 2001; 39: 321–328.
   Google Scholar
• Fukuda T, Naka W, Tajima S, Nishikawa T. Neutral red assay in minimum fungicidal concentrations of antifungal agents. J Med Vet Mycol 1996; 34: 353–356.
   PubMedGoogle Scholar
• Clayton YM. Relevance of broad-spectrum and fungicidal activity of antifungals in the treatment of dermatomycoses. Br J Dermatol 1994; 130(S43): 7–8.
   PubMedGoogle Scholar
• Faergemann J, Zehender H, Denouel J, Millerioux L. Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (with-out stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once per day for four weeks. Acta Derm Venereol 1993; 73: 305–309.
   PubMed Web of Science ®Google Scholar
• Faergemann J, Zehender H, Millerioux L. Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once daily for 7 and 14 days. Clin Exp Dermatol 1994; 19: 121–126.
   Google Scholar
• Evans EG, Sigurgeirsson B. Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. The LION Study Group. Br Med J 1999; 318: 1031–1035.
   Google Scholar
• Heikkila H, Stubb S. Long-term results in patients with onycho-mycosis treated with terbinafine or itraconazole. Br J Dermatol 2002; 146: 250–253.
   PubMed Web of Science ®Google Scholar
• Cribier BJ, Paul C. Long-term efficacy of antifungals in toenail onychomycosis: a critical review. Br J Dermatol 2001; 145: 446–452.
   PubMed Web of Science ®Google Scholar
• National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi. Approved standard M38-A. Wayne, PA: NCCLS, 2000.
   Google Scholar
• Favre B, Hofbauer B, Hildering KS, Ryder NS. Comparison of in vitro activities of 17 antifungal drugs against a panel of 20 dermatophytes by using a microdilution assay. J Clin Microbiol 2003; 41: 4817–4819.
   PubMed Web of Science ®Google Scholar
• Takasuka T. Amino acid- or protein-dependent growth of Trichophyton mentagrophytes and Trichophyton rubrum. FEMS Immunol Med Mic 2000; 29: 241–245.
   PubMedGoogle Scholar
• Rashid A, Scott EM, Richardson MD. Inhibitory effect of terbinafine on the invasion of nails by Trichophyton mentagro-phytes. J Am Acad Dermatol 1995; 33(5 Pt 1): 718–723.
   Google Scholar
• Rashid A, Scott E, Richardson MD. Early events in the invasion of the human nail plate by Trichophyton mentagrophytes. Br J Dermatol 1995; 133: 932–940.
   Google Scholar
• Richardson MD. Effect of Lamisil and azole antifungals in experimental nail infection. Dermatology 1997; 194(S1): 27–31.
   PubMedGoogle Scholar
• Okeke CN, Tsuboi R, Kawai M, Ogawa H. Fluorometric assessment of in vitro antidermatophytic activities of antimycotics based on their keratin-penetrating power. J Clin Microbiol 2000; 38: 489–491.
   PubMed Web of Science ®Google Scholar
• Oycka CA, Gugnani HC. Keratin degradation by Scytalidium species and Fusarium solani. Mycoses 1997; 41: 73–76.
   Web of Science ®Google Scholar
• Jessup CJ, Warner J, Isham N, Hasan I, Ghannoum MA. Antifungal susceptibility testing of dermatophytes: establishing a medium for inducing conidial growth and evaluation of susceptibility of clinical isolates. J Clin Microbiol 2000; 38: 341–344.
   Google Scholar
• Seebacher C. Limits of brief treatment of onychomycoses. Hautarzt 1998; 49: 705–708.
   PubMed Web of Science ®Google Scholar
• Arrese JE, Pierard-Franchimont C, Pierard GE. A plea to bridge the gap between antifungals and the management of onychomy-cosis. Am J Clin Dermatol 2001; 2: 281— 284.
   Google Scholar
• Mukherjee PK, Leidich SD, Isham N, Leitner I, Ryder NS, Ghannoum MA. Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine. Ant imicrob Ag Chemother 2003; 47: 82–86.
   PubMed Web of Science ®Google Scholar